Lismore Base Hospital is a major public teaching hospital in the Northern Rivers region of New South Wales, Australia, located in the city of Lismore. It has approximately 260 beds, and serves as the primary hospital and recognised trauma centre for the Northern New South Wales Local Health District.

There are 260 beds in Lismore Base Hospital.

During the past decade, Lismore Base Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 6 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lismore Base Hospital" #1 sponsor was "EMD Serono Research & Development Institute, Inc." with 2 trials, followed by "ETOP IBCSG Partners Foundation" with 2 trials sponsored, "Australasian Gastro-Intestinal Trials Group" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "DiaMedica Therapeutics Inc" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lismore Base Hospital" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Health Research Council, New Zealand" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator and "National Health and Medical Research Council, Australia" with 2 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Lismore Base Hospital" are "Prostate Cancer" (4 trials), "Breast Cancer" (3 trials), "Acute Coagulopathy" (1 trials), "Acute Ischemic Stroke" (1 trials) and "Breast Adenocarcinoma" (1 trials). Many other conditions were trialed in "Lismore Base Hospital" in a lesser frequency.

Most popular intervention types in "Lismore Base Hospital" are "Drug" (15 trials), "Other" (4 trials), "Biological" (2 trials), "Radiation" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Avelumab" (2 trials), "Docetaxel" (2 trials), "Paclitaxel" (2 trials) and "Abemaciclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lismore Base Hospital" are 10 trials for "All" genders, 4 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Lismore Base Hospital". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Lismore Base Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lismore Base Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".